Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

June 5, 2017

As the U.S. looks to maintain its global leadership in biopharmaceutical research and development, three new reports point to an increasingly competitive global environment.

Read More

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

June 1, 2017

A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) in partnership with The American Cancer Society Cancer Action Network (ACS CAN) finds there are more than 240 immuno-oncology medicines and vaccines currently in development.

Read More

PhRMA Statement on Intellectual Property Enforcement Coordinator

May 24, 2017

PhRMA released the following statement on the appointment of Vishal Amin as Intellectual Property Enforcement Coordinator.

Read More

America’s Biopharmaceutical Companies Unveil TV Ad Showcasing New World of Medicine

May 15, 2017

PhRMA unveiled its latest advertisement as part of its groundbreaking GOBOLDLY™ campaign, titled New World, featuring some of the most extraordinary breakthroughs in science being discovered by biopharmaceutical researchers.

Read More

PhRMA Statement Following Meeting With HHS Secretary Price

May 12, 2017

PhRMA president and CEO Stephen J. Ubl issued a statement following a meeting with HHS Secretary Price.

Read More

PhRMA Board of Directors Establishes New Membership Criteria

May 9, 2017

Demonstrating its commitment to representing research- based biopharmaceutical companies, the board of directors for the Pharmaceutical Research and Manufacturers of America (PhRMA) today approved new criteria for membership.

Read More

PhRMA Statement on 2017 Special 301 Report

April 28, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Jay Taylor issued the following statement today:

Read More

New Ads from America’s Biopharmaceutical Companies Feature Patients and Unsung Heroes Behind Cutting-Edge Scientific Advances

April 19, 2017

New Ads from America’s Biopharmaceutical Companies Feature Patients and Unsung Heroes Behind Cutting-Edge Scientific Advances

Read More

PhRMA Statement on MedPAC Vote

April 6, 2017

PhRMA spokesperson Allyson Funk issued the following statement on the MedPAC vote.

Read More

PhRMA Launches New “Share the Savings” Campaign to Urge Payers to Share Negotiated Discounts with Patients  

April 6, 2017

The Pharmaceutical Research and Manufacturers of America (PhRMA) today unveiled “Share the Savings,” a new campaign to educate the public about the lack of rebate pass-through for commercially insured patients with high deductibles and coinsurance.

Read More